Home > Financial Ratios > BAL PHARMA

BAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 7.788.238.9410.845.60

What is the latest Price to Cash Earnings (PCE) ratio of BAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of BAL PHARMA is 7.78 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar20257.78
Mar20248.23
Mar20238.94
Mar202210.84
Mar20215.60

How is Price to Cash Earnings (PCE) of BAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 7.78
-5.47
Mar2024 8.23
-7.94
Mar2023 8.94
-17.53
Mar2022 10.84
93.57
Mar2021 5.6 -

Other Financial Ratios of BAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹131.9 Cr -0.7% -4% -34.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,682.0 Cr -2.5% -0.2% -15.2% Stock Analytics
DIVIS LABORATORIES ₹150,985.0 Cr -5.9% -6.9% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,862.0 Cr -1.9% 0.7% 3.9% Stock Analytics
CIPLA ₹121,294.0 Cr -2.6% -6.4% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹102,132.0 Cr -5.6% -2.2% -6.4% Stock Analytics


BAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-0.7%

-4%

-34.1%

SENSEX

-2.2%

0.6%

-5.8%


You may also like the below Video Courses